Search Results
10
Everything
Search Filters
Tag
Pharmaceutical
French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
November 11, 2024 12:43 ET
|
AdipoPharma
STRASBOURG, France, Nov. 11, 2024 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the US and Belgium developing a novel and promising Type 2 diabetes drug,...
EvolveImmune Therapeutics Presents New Preclinical and Translational Data Highlighting Pipeline Progress for EVOLVE T Cell Engager Platform at 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 11, 2024 07:00 ET
|
EvolveImmune
Poster Presentations Spotlight Differentiated Therapeutic Profile and Precision Therapeutic Strategy for Lead Development Candidate EVOLVE104 as Program Advances Toward Clinic for Solid Tumors EVOLVE...
Vielversprechende Kooperation zwischen medac und chiron zur Entwicklung von Organ-on-chip Technologie
November 07, 2024 09:00 ET
|
medac Gesellschaft für klinische Spezialpräparate mbH
WEDEL, Deutschland, Nov. 07, 2024 (GLOBE NEWSWIRE) -- In der Arzneimittelentwicklung sind Tierversuche zurzeit noch ein regulatorisch verankerter Bestandteil, gleichzeitig schreitet die Entwicklung...
Promising cooperation between medac and chiron for the development of organ-on chip technology
November 07, 2024 09:00 ET
|
medac Gesellschaft für klinische Spezialpräparate mbH
WEDEL, Germany, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Testing new substances in animals is a regulatory cornerstone of drug development. At the same time, the development of animal free testing methods...
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
November 07, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
SynOx Therapeutics Further Strengthens Executive Team with Appointments of U.S.-Based Chief Medical Officer and Chief Commercial Officer
November 07, 2024 07:00 ET
|
SynOx Therapeutics Limited
Additions of Elyse Seltzer, M.D., as CMO and Robert Francomano as CCO Strengthen Company’s Presence in the U.S. Seasoned Team to Drive Forward Pivotal Phase 3 Trial of Emactuzumab in Patients...
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
November 05, 2024 09:00 ET
|
PrognomiQ
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
Olon ist bereit für die Produktion in der neuen Anlage für hoch starke Wirkstoffe
November 04, 2024 05:00 ET
|
Olon SpA
MAILAND, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Olon, ein Arzneimittelhersteller und globales CDMO-Unternehmen, bestätigt den Zeitplan für den Bau seiner neuen Produktionsanlage für hoch starke...
Olon est prête à lancer la production dans sa nouvelle installation dédiée aux composés ultra-puissants
November 04, 2024 05:00 ET
|
Olon SpA
MILAN, 04 nov. 2024 (GLOBE NEWSWIRE) -- Olon, fournisseur d’API et acteur mondial dans le domaine des CDMO, confirme le respect du calendrier de construction de sa nouvelle installation dédiée aux...
Olon is ready to host productions in the new facility dedicated to ultra-potent compounds
November 04, 2024 05:00 ET
|
Olon SpA
Olon is ready to host productions
in the new facility dedicated to ultra-potent compounds